PHILADELPHIA--(BUSINESS WIRE)--Techulon Inc., an early stage life sciences company has joined KFP—the KeraFAST Partner Program, adding its innovative new transfection reagent, Glycofect™, to KeraFAST’s portfolio of research products for the cell biologist. The agreement was announced during the 50th Annual Meeting of the American Society for Cell Biology. Glycofect is a polymeric transfection reagent designed to be particularly effective in primary cells of therapeutic interest. It is being used worldwide by government, university and corporate laboratories for advanced research towards better understanding of cell biology and for development of new cell-based therapeutics.
